IP Library Granted Patent US 9,623,261
Granted Patent B2
US 9,623,261 · App. 13/262,629 · Granted Apr 18, 2017

Components and assembly for performing brachytherapy treatment of tumour tissue in a human and animal body

Inventors: Cor Van De Wardt (Kesteren, NL); Emil Matthijs Buijs (Veenendaal, NL); Arie Luite Visscher (Driebergen, NL)
Assignee: Nucletron B.V.
A61N5/1016A61B90/11A61M25/01A61M37/00A61N5/1027A61B17/4241A61B2017/3411A61N2005/1008A61N2005/1012A61N2005/1018
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,623,261
App. No.
13/262,629
Granted
Apr 18, 2017
Kind
B2
Abstract

The invention relates to an assembly for performing brachytherapy treatment of tumor tissue in a human or animal body comprising an intracavitary component and at least one guiding unit, said at least one guiding unit exhibiting a longitudinal axis and being connectable to said intracavitary component, and wherein said at least one guiding unit is provided with coupling means for coupling at least one interstitial needle-assembly for delivering treatment to said tumor tissue. The assembly has coupling/uncoupling means arranged to allow a displacement of said at least one interstitial needle-assembly in a direction transverse to said longitudinal axis and to prevent a displacement of said at least one interstitial needle-assembly in a direction parallel to or a pre-defined angle to said longitudinal axis. This coupling principle allows for the preparation of the guiding unit before the patient is being hospitalized and positioned in the treatment room and will prevent the unwanted uncoupling of the interstitial needle-assembly during the actual treatment being performed, further reducing the risk of adversely affected treatment parameters (location and duration of the radiation being administered to the patient).

Claims (16)

1. An assembly for performing brachytherapy treatment of tumour tissue in a human or animal body, comprising:

an interstitial needle-assembly for delivering treatment to the tumour tissue and having a hollow catheter channel and a guidance channel through which the hollow catheter channel is movable,

an intracavitary component for insertion into a body cavity, and

a guiding unit, wherein the guiding unit has a longitudinal axis and is connectable to the intracavitary component,

wherein the guiding unit is releasably connected to a distal end of the guidance channel by a coupler such that passage of the hollow catheter channel through a guidance opening in the guiding unit secures the guidance channel to the guiding unit, and

wherein the guidance channel has a proximal end provided with a securing element configured to secure the hollow catheter channel against movement in a direction parallel to the longitudinal axis.

2. The assembly according to claim 1 , wherein the coupler comprises at least one recess for accommodating, during use, at least part of the interstitial needle-assembly.

3. The assembly according to claim 2 , and having the at least one recess provided in a circumferential surface of the guiding unit.

4. The assembly according to claim 3 , in which the distal end of the guidance channel is to be accommodated in the at least one recess.

5. The assembly according to claim 4 , in which the distal end of the guidance channel is provided with a first connection element fitting the at least one recess.

6. The assembly according to claim 5 , in which the at least one recess comprises at least a first recess part, which continues to a second recess part and wherein the first connection element is provided with at least a first element part fitting the first recess part as well as a second element part fitting the second recess part.

7. The assembly according to claim 2 , in which the at least one recess continues in the guidance opening running through the guiding unit.

8. The assembly according to claim 1 , in which the guiding unit has a ring shape surrounding the intracavitary component.

9. The assembly according to claim 1 , wherein the hollow catheter channel can be displaced in a direction transverse to the longitudinal axis after passage through the opening in the guiding unit.

10. The assembly according to claim 1 , wherein the coupler prevents displacement of the guidance channel in a direction parallel to the longitudinal axis.

11. The assembly according to claim 1 , wherein the coupler allows displacement of the guidance channel in a direction transverse to the longitudinal axis when the hollow catheter channel is removed from the guidance opening.

Assignments (2)
CHANGE OF NAME Recorded Jul 12, 2012
From: NUCLETRON B.V.
To: NUCLETRON OPERATIONS B.V.
Reel/Frame 028539/0494 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2011
From: VAN DE WARDT, COR; BUIJS, EMIL MATTHIJS; VISSCHER, ARIE LUITE
To: NUCLETRON B.V.
Reel/Frame 027068/0645 →
Priority Claims (1)
EP 09004815 · Apr 1, 2009 · regional
Continuity (1)
Related Publication 20120029263A1 · Feb 2, 2012